---
figid: PMC2941781__vhrm-6-671f4
figtitle: Pioglitazone positively affects the insulin signaling system resulting in
  improved glycemic control, generation of nitric oxide and decreased MAP kinase pathway
  activation
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC2941781
filename: vhrm-6-671f4.jpg
figlink: /pmc/articles/PMC2941781/figure/f4-vhrm-6-671/
number: F4
caption: Pioglitazone positively affects the insulin signaling system resulting in
  improved glycemic control, generation of nitric oxide and decreased MAP kinase pathway
  activation.
papertitle: 'Pioglitazone and alogliptin combination therapy in type 2 diabetes: a
  pathophysiologically sound treatment.'
reftext: Curtis Triplitt, et al. Vasc Health Risk Manag. 2010;6:671-690.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9671772
figid_alias: PMC2941781__F4
figtype: Figure
redirect_from: /figures/PMC2941781__F4
ndex: 6e4a62c4-deca-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2941781__vhrm-6-671f4.html
  '@type': Dataset
  description: Pioglitazone positively affects the insulin signaling system resulting
    in improved glycemic control, generation of nitric oxide and decreased MAP kinase
    pathway activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Eaat1
  - Glut1
  - Glut4EF
  - Glut3
  - Myb
  - Pi3K21B
  - Taf5
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - Akt
  - Shc
  - mapP
  - SLC2A4
  - SLC2A1
  - IRS1
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - AKT1
  - AKT2
  - AKT3
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - SGSM3
---
